CLINICAL_TRIALS
research
· 2026-02-02
Clinical Trial Update: Anti-PD 1 Brain Collaboration + Radiotherapy Extension (ABC-X Study) [Phase 2]
Summary
Phase 2 clinical trial named ABC-X Study is evaluating an anti-PD-1 therapy in melanoma with radiotherapy extension, currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Melanoma Institute Australia | Conditions: Melanoma Stage Iv | Phase 2 | Status: RECRUITING